Hypogonadism MRI: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. {{Hypogonadism}} {{CMG}} ==Overview==...") |
|||
| (7 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hypogonadism}} | |||
{{CMG}}; {{AE}} {{AEL}} | |||
==Overview== | ==Overview== | ||
MRI is performed in cases of hypogonadism to examine the [[pituitary gland]] and [[hypothalamus]] to detect any [[tumors]] that may cause hypogonadism. It is performed in specific patients who present with [[Visual impairment|visual disorders]], [[Neurological illness|neurological manifestations]] and lab findings of [[hypopituitarism]]. Possible findings may include empty [[sella turcica]] and [[pituitary adenomas]]. | |||
==MRI== | ==MRI== | ||
* [[MRI]] may be used in cases of hypogonadism to examine [[pituitary gland]] for any pituitary or [[Hypothalamus|hypothalamic]] [[tumors]] causing [[Disease|the disease]]. However, the chance of finding pituitary and hypothalamic tumors in hypogonadism patients is very low.<ref name="pmid8558653">{{cite journal| author=Citron JT, Ettinger B, Rubinoff H, Ettinger VM, Minkoff J, Hom F et al.| title=Prevalence of hypothalamic-pituitary imaging abnormalities in impotent men with secondary hypogonadism. | journal=J Urol | year= 1996 | volume= 155 | issue= 2 | pages= 529-33 | pmid=8558653 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8558653 }}</ref> | |||
* Brain [[MRI contrast agent|MRI]] is helpful if the patient present with the following features: | |||
** [[Visual impairment|Visual disorders]] | |||
** [[Neurological illness|Neurological manifestations]] | |||
** Lab results showing [[hypopituitarism]] | |||
* Possible [[MRI]] findings in hypogonadism include: | |||
** Empty [[sella turcica]]: the sella is filled with cerebrospinal fluid ([[CSF]]) and the [[infundibulum]] can be seen to traverse the space, thereby excluding a cystic mass. | |||
** [[Pituitary gland|Pituitary]] micro or macro [[adenomas]]. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 13: | Line 24: | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Urologic Surgery]] | [[Category:Urologic Surgery]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
Latest revision as of 20:26, 3 October 2017
|
Hypogonadism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypogonadism MRI On the Web |
|
American Roentgen Ray Society Images of Hypogonadism MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
MRI is performed in cases of hypogonadism to examine the pituitary gland and hypothalamus to detect any tumors that may cause hypogonadism. It is performed in specific patients who present with visual disorders, neurological manifestations and lab findings of hypopituitarism. Possible findings may include empty sella turcica and pituitary adenomas.
MRI
- MRI may be used in cases of hypogonadism to examine pituitary gland for any pituitary or hypothalamic tumors causing the disease. However, the chance of finding pituitary and hypothalamic tumors in hypogonadism patients is very low.[1]
- Brain MRI is helpful if the patient present with the following features:
- Visual disorders
- Neurological manifestations
- Lab results showing hypopituitarism
- Possible MRI findings in hypogonadism include:
- Empty sella turcica: the sella is filled with cerebrospinal fluid (CSF) and the infundibulum can be seen to traverse the space, thereby excluding a cystic mass.
- Pituitary micro or macro adenomas.
References
- ↑ Citron JT, Ettinger B, Rubinoff H, Ettinger VM, Minkoff J, Hom F; et al. (1996). "Prevalence of hypothalamic-pituitary imaging abnormalities in impotent men with secondary hypogonadism". J Urol. 155 (2): 529–33. PMID 8558653.